Type(s) of breast cancer-Ductal carcinoma Page 2 Posts on Medivizor
Navigation Menu

Type(s) of breast cancer-Ductal carcinoma Posts on Medivizor

Hormone therapy; enabling surgery in post-menopausal breast cancer patients

Posted by on Jun 11, 2015 in Breast cancer | 0 comments

In a nutshell The authors aimed to determine the long-term effects of hormone therapy to treat post-menopausal women with advanced breast cancer. Some background Hormone therapy is a form of breast cancer treatment. It targets cancer cells that may be affected by hormones. It is often administered prior to surgery in patients who are unfit to...

Read More

Is the removal of the breast a reliable treatment for women with low-risk early breast cancer?

Posted by on May 20, 2015 in Breast cancer | 0 comments

In a nutshell The authors aimed to study the best course of surgical treatment for women with low-risk early breast cancer. Some background Breast-conserving therapy (the removal of the tumor and some surrounding breast tissue) is often recommended for women with early breast cancer. It is generally followed by radiation therapy (using radiation...

Read More

Chemotherapy before surgery; is there a different in outcome between different types of breast cancer?

Posted by on May 14, 2015 in Breast cancer | 0 comments

In a nutshell The authors aimed to evaluate if the outcomes of surgery following chemotherapy are different based on the focality of breast cancer tumors.  Some background Breast cancer can be characterised as 'unifocal', 'multifocal and 'multicentric'. This refers to the number of areas in which the cancer can be found...

Read More

Can Zometa improve survival rate?

Posted by on Nov 4, 2013 in Breast cancer | 0 comments

In a nutshell This study investigated the influence of zoledronic acid (Zometa) on disseminated tumor cell (DTC) and survival of early stage breast cancer patients. Some background DTC are tumor cells that can be found in the bone marrow (the fatty and bloody tissue that fills the bone cavities and is the source of red blood cells and many white...

Read More

A review of pertuzumab and its use in HER2 blockade

Posted by on Aug 23, 2013 in Breast cancer | 0 comments

In a nutshell This article reviewed data from recent clinical trials investigating the drug pertuzumab (perjeta) as treatment for metastatic HER2+ breast cancer. Some background HER2 (human epidermal growth factor receptor 2) is a protein found on the surface of some cancer cells. This complex responds to molecules called growth factors, and...

Read More

Comparing survival after mastectomy and lumpectomy in patients with early-stage breast cancer

Posted by on Jun 28, 2013 in Breast cancer | 0 comments

In a nutshell The study compared survival rates in patients with early stage breast cancer treated with mastectomy versus lumpectomy plus radiation therapy. Some background Most breast cancers grow in response to female hormones (estrogen or progesterone), via their receptor (a protein found on the surface of the cancer cells). These cancers are...

Read More

Evaluating chemotherapy options for patients with triple negative breast cancer

Posted by on Jun 17, 2013 in Breast cancer | 0 comments

In a nutshell This article looked at the use of a platinum based chemotherapy (cisplatin) to a non-platinum based chemotherapy for patients with triple negative breast cancer. Some background Most breast cancers have on their surface some proteins called receptors that help the breast cancers grow. These can be hormone receptors (estrogen or...

Read More

Phase 3 clinical trial comparing the addition of anastrozole versus tamoxifen to goserelin therapy before surgery for patients with early-stage breast cancer

Posted by on Jun 5, 2013 in Breast cancer | 0 comments

In a nutshell This phase 3 clinical trial compared the safety and efficacy of two different combination treatments in women with early stage breast cancer: anastrozole (Arimidex) plus goserelin (Zoladex) versus tamoxifen (Nolvadex) plus goserelin. Some background An estrogen-receptor positive (ER+) breast cancer requires estrogen (the primary...

Read More

Risk of Heart Failure after Anthracycline (Adriamycin/Daunomycin) and Trastuzumab (Herceptin) Treatments for Breast Cancer

Posted by on Mar 19, 2013 in Breast cancer | 0 comments

In a nutshell This study evaluated the risk of heart disease associated with two commonly prescribed treatments for breast cancer. The main finding was that Trastuzumab (Herceptin) and Anthracycline (Adriamycin/Daunomycin) treatments are associated with a higher risk of heart failure or ‘cardiomyopathy’. Some background Anthracyclines...

Read More